FDA Calls for Stronger Warnings on Diabetes Drugs

By Admin on June 06, 2007 | Last updated on March 21, 2019

The U.S. Food and Drug Administration (FDA) has decided to require that the agency's strongest health warning be added to labeling for the diabetes drugs Avandia and Actos, according to a New York Times article. According to the Times, due to concerns over heart risks associated with the diabetes medications, "the agency was asking the makers of Actos and Avandia to carry a more prominent warning of its heart risks because 'despite existing warnings, these drugs were being prescribed to patients with significant heart failure.'" Word of the decision came from FDA Commissioner Andrew C. von Eschenbach, during a U.S. House of Representatives Committee on Oversight and Government Reform hearing discussing potential FDA reform. 

Copied to clipboard